ヒト成長ホルモンの世界市場レポート 2025年

ヒト成長ホルモン市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.8％で76億米ドルに成長します。予測期間の成長は、個別化医療の出現、世界のヘルスケア支出の増加、組換えDNA技術の採用拡大、ホルモン補充療法の需要拡大、内分泌疾患の有病率の上昇などに起因すると考えられます。予測期間における主な動向としては、新興国市場における流通網の拡大、医薬品開発における人工知能の統合、持続可能な製造プロセスの重視、長時間作用型製剤の開発、有効性向上のための併用療法の活用などが挙げられます。

治療手順に対する意識の高まりが、今後のヒト成長ホルモン市場の拡大を牽引すると予想されます。治療には、健康状態や疾患の緩和、管理、治癒を目的とした医療介入が含まれます。このような意識の高まりは、医療技術の進歩、デジタルメディアを通じた情報へのアクセス強化、健康とウェルネスに対する人々の関心の高まりによって後押しされています。ヒト成長ホルモン（HGH）治療は、メディアの大きな注目と一般の人々の関心を集め、最新の医療介入の利点と潜在的な応用を強調し、それによって治療手順に対する全体的な認識を高めています。例えば、薬物乱用・精神衛生管理局（SAMHSA）による2022年薬物使用と健康に関する全国調査（NSDUH）報告書によると、12歳から17歳の青少年のうち、2021年には、過去1年間に大うつ病エピソード（MDE）を経験した500万人の青少年のうち40.6％がうつ病の治療を受けており、2022年には、過去1年間にMDEを経験した480万人の青少年のうち56.8％がメンタルヘルス治療を受けています。その結果、治療手順に対する意識の高まりがヒト成長ホルモン市場の成長を後押ししています。

ヒト成長ホルモン市場の主要企業は、医薬品を充実させ、優れた治療ソリューションを提供するために、医薬品開発と承認への取り組みを強化しています。医薬品開発には、新薬が市場に導入される前に、その安全性、有効性、品質を確保するための複数の段階を含む包括的で綿密なプロセスが含まれます。例えば、2023年6月、米国のバイオ医薬品会社であるファイザー社と、米国のバイオ医薬品・診断薬会社であるOPKO Health Inc.は、NGENLA（somatrogon-ghla）が食品医薬品局（FDA）から承認されたことを発表しました。この治療は、毎日注射するよりも便利な投与方法を提供し、患者の服薬アドヒアランスを高めます。成長ホルモン欠乏症の小児に、注射の頻度を毎日から週1回に減らす選択肢を提供します。FDAの承認は、NGENLAが1日1回投与のソマトロピンに対して非劣性であり、安全性プロファイルはソマトロピンと同等であることを実証した第3相試験によって支持されました。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ヒト成長ホルモンPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のヒト成長ホルモン市場：成長率分析
• 世界のヒト成長ホルモン市場の実績：規模と成長, 2019-2024
• 世界のヒト成長ホルモン市場の予測：規模と成長, 2024-2029, 2034F
• 世界ヒト成長ホルモン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のヒト成長ホルモン市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 液体
• 粉
• 世界のヒト成長ホルモン市場ブランド別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ノルディトロピン
• ジェノトロピン
• ヒューマトロープ
• サイゼン
• オムニトロープ
• スカイトロファ
• その他のブランド
• 世界のヒト成長ホルモン市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 静脈内
• 筋肉内
• 皮下
• 世界のヒト成長ホルモン市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 専門薬局
• 世界のヒト成長ホルモン市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 成長ホルモン（GH）欠乏症
• 成人成長ホルモン（GH）欠乏症
• 小児成長ホルモン（GH）欠乏症
• ターナー症候群
• 特発性低身長
• プラダー・ウィリー症候群
• 妊娠週数に対して小さい
• その他の用途
• 世界のヒト成長ホルモン市場、液体の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• プレフィルドシリンジ
• 液体成長ホルモンのバイアル
• 世界のヒト成長ホルモン市場、粉末の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 再構成可能な粉末
• 凍結乾燥粉末

第7章 地域別・国別分析

• 世界のヒト成長ホルモン市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のヒト成長ホルモン市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ヒト成長ホルモン市場：競合情勢
• ヒト成長ホルモン市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Novo Nordisk A/S
• Merck KGaA
• Teva Pharmaceutical Industries Ltd.
• Sandoz International GmbH
• Ipsen Pharma
• Ferring Holding SA
• Endo International
• Zydus Lifesciences Limited
• Opko Health
• LG Life Sciences
• EMD Serono Inc.
• Wockhardt Ltd.
• JCR Pharmaceuticals Co. Ltd.
• Genentech Inc.
• Shanghai United Imaging Healthcare Co. Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ヒト成長ホルモン市場2029：新たな機会を提供する国
• ヒト成長ホルモン市場2029：新たな機会を提供するセグメント
• ヒト成長ホルモン市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Human growth hormone (HGH) is a peptide hormone originating from the pituitary gland, playing a vital role in encouraging growth, cell replication, and tissue renewal across the human body. It finds application in medical interventions targeting growth hormone deficiency, promoting muscle growth, and addressing age-related issues such as muscle atrophy and decreased bone density.

The primary forms of human growth hormone are liquid and powder. Liquid human growth hormone products are typically presented as a solution or suspension, readily available for immediate consumption or injection. These include various brands such as Norditropin, Genotropin, Humatrope, Saizen, Omnitrope, Skytrofa, among others, administered via different routes such as oral, intravenous, intramuscular, or subcutaneous. These products are distributed through diverse channels such as hospital pharmacies, retail pharmacies, online pharmacies, and specialty pharmacies, catering to a range of applications such as growth hormone (GH) deficiency, adult GH deficiency, pediatric GH deficiency, Turner syndrome, idiopathic short stature, Prader-Willi syndrome, small for gestational age, and others.

The human growth hormone market research report is one of a series of new reports from The Business Research Company that provides human Growth hormone market statistics, including human growth hormone industry global market size, regional shares, competitors with a human growth hormone market share, detailed human growth hormone market segments, market trends, and opportunities, and any further data you may need to thrive in the human growth hormone industry. This human growth hormone market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The human growth hormone market size has grown rapidly in recent years. It will grow from $4.75 billion in 2024 to $5.23 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to increasing prevalence of growth disorders, rising awareness about hormone therapies, expanding applications in sports medicine, growing geriatric population, improving healthcare infrastructure.

The human growth hormone market size is expected to see strong growth in the next few years. It will grow to $7.6 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to emergence of personalized medicine, rising healthcare expenditure globally, increasing adoption of recombinant DNA technology, growing demand for hormone replacement therapies, rising prevalence of endocrine disorders. Major trends in the forecast period include expansion of distribution networks in emerging markets, integration of artificial intelligence in drug development, emphasis on sustainable manufacturing processes, development of long-acting formulations, utilization of combination therapies for enhanced efficacy.

The increasing awareness of treatment procedures is anticipated to drive the expansion of the human growth hormone market in the future. Treatment procedures encompass medical interventions aimed at alleviating, managing, or curing health conditions or diseases. This heightened awareness is fueled by advancements in medical technology, enhanced access to information via digital media, and a growing public interest in health and wellness. Human growth hormone (HGH) treatments have attracted significant media attention and public interest, underscoring the benefits and potential applications of modern medical interventions, thereby boosting overall awareness of treatment procedures. For example, according to the 2022 National Survey on Drug Use and Health (NSDUH) report by the Substance Abuse and Mental Health Services Administration (SAMHSA), among adolescents aged 12 to 17, in 2021, 40.6% of the 5.0 million adolescents with a past year Major Depressive Episode (MDE) received treatment for depression, while in 2022, 56.8% of the 4.8 million adolescents with a past year MDE received mental health treatment. Consequently, the heightened awareness of treatment procedures is propelling the growth of the human growth hormone market.

Leading companies in the human growth hormone market are intensifying their efforts in drug development and approvals to enhance their medication offerings and provide superior treatment solutions. Drug development entails a comprehensive and meticulous process involving multiple stages to ensure the safety, efficacy, and quality of a new drug before it is introduced to the market. For example, in June 2023, Pfizer Inc., a US-based biopharmaceutical company, and OPKO Health Inc., a US-based biopharmaceutical and diagnostics company, announced the approval of NGENLA (somatrogon-ghla) by the Food and Drug Administration (FDA). This treatment offers a more convenient dosing regimen and enhances patient adherence compared to daily injections. It provides children with growth hormone deficiency the option to reduce injection frequency from daily to once a week. The FDA approval was supported by a Phase 3 study demonstrating NGENLA's non-inferiority to once-daily somatropin, with a safety profile comparable to somatropin.

The increasing healthcare expenditure is expected to drive the growth of the human growth hormone (HGH) market in the coming years. Healthcare expenditure refers to the total spending on health services, products, and interventions aimed at improving and maintaining health. HGH therapy provides a unique approach to reducing healthcare costs by addressing underlying health issues that contribute to long-term expenses, enhancing recovery and quality of life, and potentially preventing the onset of expensive chronic conditions. For instance, in May 2023, a report from the Office for National Statistics, a UK-based government agency, indicated that healthcare spending in the UK grew by 5.6% between 2022 and 2023, compared to just 0.9% in 2022. The total healthcare expenditure in the UK was approximately $317.63 billion (£292 billion) in 2023. As a result, the rise in healthcare spending is expected to drive the human growth hormone market forward.

Major companies operating in the human growth hormone market are Pfizer Inc., Roche Holding AG, Novartis AG, Thermo Fisher Scientific Inc., Eli Lilly and Company, Novo Nordisk A/S, Merck KGaA, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Ipsen Pharma, Ferring Holding SA, Endo International, Zydus Lifesciences Limited, Opko Health, LG Life Sciences, EMD Serono Inc., Wockhardt Ltd., JCR Pharmaceuticals Co. Ltd., Genentech Inc., Shanghai United Imaging Healthcare Co. Ltd., SOFAR S.p.A., United Laboratories, Ascendis Pharma, Uni-Pharma S.A., Versartis Inc., Reliance Life Sciences, Anhui Anke Biotechnology (Group) Co. Ltd., Rani Therapeutics

North America was the largest region in the human growth hormone market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human growth hormone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the human growth hormone market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The human growth hormone market consists of sales of combination therapies, sustained-release formulations, long-acting formulations, biosimilar versions, pediatric-specific formulations, and personalized dosing regimens. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Human Growth Hormone Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on human growth hormone market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for human growth hormone ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The human growth hormone market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Liquid; Powder
• 2) By Brand: Norditropin; Genotropin; Humatrope; Saizen; Omnitrope; Skytrofa; Others Brands
• 3) By Route Of Administration: Oral; Intravenous; Intramuscular; Subcutaneous
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacy; Specialty Pharmacy
• 5) By Application: Growth Hormone (GH) Deficiency; Adult Growth Hormone (GH) Deficiency; Pediatric Growth Hormone (GH) Deficiency; Turner Syndrome; Idiopathic Short Stature; Prader-Willi Syndrome; Small For Gestational Age; Other Applications
• Subsegments:
• 1) By Liquid: Pre-Filled Liquid Syringes; Vials Of Liquid Growth Hormone
• 2) By Powder: Reconstitutable Powder; Freeze-Dried Powder
• Companies Mentioned: Pfizer Inc.; Roche Holding AG; Novartis AG; Thermo Fisher Scientific Inc.; Eli Lilly and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Human Growth Hormone Market Characteristics

3. Human Growth Hormone Market Trends And Strategies

4. Human Growth Hormone Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Human Growth Hormone Growth Analysis And Strategic Analysis Framework

• 5.1. Global Human Growth Hormone PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Human Growth Hormone Market Growth Rate Analysis
• 5.4. Global Human Growth Hormone Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Human Growth Hormone Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Human Growth Hormone Total Addressable Market (TAM)

6. Human Growth Hormone Market Segmentation

• 6.1. Global Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Liquid
• Powder
• 6.2. Global Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Norditropin
• Genotropin
• Humatrope
• Saizen
• Omnitrope
• Skytrofa
• Others Brands
• 6.3. Global Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Intravenous
• Intramuscular
• Subcutaneous
• 6.4. Global Human Growth Hormone Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacy
• Specialty Pharmacy
• 6.5. Global Human Growth Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Growth Hormone (GH) Deficiency
• Adult Growth Hormone (GH) Deficiency
• Pediatric Growth Hormone (GH) Deficiency
• Turner Syndrome
• Idiopathic Short Stature
• Prader-Willi Syndrome
• Small For Gestational Age
• Other Applications
• 6.6. Global Human Growth Hormone Market, Sub-Segmentation Of Liquid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pre-Filled Liquid Syringes
• Vials Of Liquid Growth Hormone
• 6.7. Global Human Growth Hormone Market, Sub-Segmentation Of Powder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reconstitutable Powder
• Freeze-Dried Powder

7. Human Growth Hormone Market Regional And Country Analysis

• 7.1. Global Human Growth Hormone Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Human Growth Hormone Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Human Growth Hormone Market

• 8.1. Asia-Pacific Human Growth Hormone Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Human Growth Hormone Market

• 9.1. China Human Growth Hormone Market Overview
• 9.2. China Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Human Growth Hormone Market

• 10.1. India Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Human Growth Hormone Market

• 11.1. Japan Human Growth Hormone Market Overview
• 11.2. Japan Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Human Growth Hormone Market

• 12.1. Australia Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Human Growth Hormone Market

• 13.1. Indonesia Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Human Growth Hormone Market

• 14.1. South Korea Human Growth Hormone Market Overview
• 14.2. South Korea Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Human Growth Hormone Market

• 15.1. Western Europe Human Growth Hormone Market Overview
• 15.2. Western Europe Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Human Growth Hormone Market

• 16.1. UK Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Human Growth Hormone Market

• 17.1. Germany Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Human Growth Hormone Market

• 18.1. France Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Human Growth Hormone Market

• 19.1. Italy Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Human Growth Hormone Market

• 20.1. Spain Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Human Growth Hormone Market

• 21.1. Eastern Europe Human Growth Hormone Market Overview
• 21.2. Eastern Europe Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Human Growth Hormone Market

• 22.1. Russia Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Human Growth Hormone Market

• 23.1. North America Human Growth Hormone Market Overview
• 23.2. North America Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Human Growth Hormone Market

• 24.1. USA Human Growth Hormone Market Overview
• 24.2. USA Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Human Growth Hormone Market

• 25.1. Canada Human Growth Hormone Market Overview
• 25.2. Canada Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Human Growth Hormone Market

• 26.1. South America Human Growth Hormone Market Overview
• 26.2. South America Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Human Growth Hormone Market

• 27.1. Brazil Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Human Growth Hormone Market

• 28.1. Middle East Human Growth Hormone Market Overview
• 28.2. Middle East Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Human Growth Hormone Market

• 29.1. Africa Human Growth Hormone Market Overview
• 29.2. Africa Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Human Growth Hormone Market Competitive Landscape And Company Profiles

• 30.1. Human Growth Hormone Market Competitive Landscape
• 30.2. Human Growth Hormone Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

31. Human Growth Hormone Market Other Major And Innovative Companies

• 31.1. Novo Nordisk A/S
• 31.2. Merck KGaA
• 31.3. Teva Pharmaceutical Industries Ltd.
• 31.4. Sandoz International GmbH
• 31.5. Ipsen Pharma
• 31.6. Ferring Holding SA
• 31.7. Endo International
• 31.8. Zydus Lifesciences Limited
• 31.9. Opko Health
• 31.10. LG Life Sciences
• 31.11. EMD Serono Inc.
• 31.12. Wockhardt Ltd.
• 31.13. JCR Pharmaceuticals Co. Ltd.
• 31.14. Genentech Inc.
• 31.15. Shanghai United Imaging Healthcare Co. Ltd.

32. Global Human Growth Hormone Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Human Growth Hormone Market

34. Recent Developments In The Human Growth Hormone Market

35. Human Growth Hormone Market High Potential Countries, Segments and Strategies

• 35.1 Human Growth Hormone Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Human Growth Hormone Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Human Growth Hormone Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer